Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.37% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 12.72% |
| 4 | Industrials | 10.14% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FIRY
1676
Firy Inc
FIRY
$150M
| $3.58M | ﹤0.01% |
301,385
-75,046
| -20% | -$995K |
|
|
DCPH
1677
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.57M | ﹤0.01% |
231,318
+140,618
| +155% | +$2.35M |
|
1678
Culp Inc
CULP
$43.7M
| $3.56M | ﹤0.01% |
685,317
-10,300
| -1% | -$55.1K |
|
1679
COPT Defense Properties
CDP
$4.22B
| $3.56M | ﹤0.01% |
150,100
+139,900
| +1,372% | +$3.6M |
|
1680
DLH Holdings
DLHC
$67.7M
| $3.55M | ﹤0.01% |
309,668
+10,300
| +3% | +$123K |
|
1681
LendingTree
TREE
$457M
| $3.55M | ﹤0.01% |
133,200
-124,000
| -48% | -$4.07M |
|
1682
Casey's General Stores
CASY
$31.6B
| $3.54M | ﹤0.01% |
16,372
-65,800
| -80% | -$14.4M |
|
1683
FS Bancorp
FSBW
$326M
| $3.54M | ﹤0.01% |
117,800
+10,155
| +9% | +$343K |
|
|
MIXT
1684
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $3.53M | ﹤0.01% |
455,800
+9,000
| +2% | +$72.1K |
|
1685
Innospec
IOSP
$2.31B
| $3.53M | ﹤0.01% |
34,362
+16,362
| +91% | +$1.76M |
|
|
CSTR
1686
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $3.52M | ﹤0.01% |
232,399
+2,900
| +1% | +$48.5K |
|
1687
M/I Homes
MHO
$3.87B
| $3.51M | ﹤0.01% |
55,600
-22,400
| -29% | -$1.29M |
|
1688
Atlanticus Holdings
ATLC
$1.52B
| $3.5M | ﹤0.01% |
128,958
-14,700
| -10% | -$442K |
|
1689
Heartland Express
HTLD
$1B
| $3.5M | ﹤0.01% |
219,749
-59,400
| -21% | -$966K |
|
|
ME
1690
DELISTED
23andMe Holding Co
ME
| $3.49M | ﹤0.01% |
76,570
+45,725
| +148% | +$2.21M |
|
1691
Adaptive Biotechnologies
ADPT
$3.88B
| $3.48M | ﹤0.01% |
394,000
-21,800
| -5% | -$192K |
|
1692
Marcus & Millichap
MMI
$1.2B
| $3.47M | ﹤0.01% |
108,100
-107,100
| -50% | -$3.72M |
|
1693
Amplitude
AMPL
$1.63B
| $3.46M | ﹤0.01% |
278,400
-42,900
| -13% | -$570K |
|
1694
Hilton Grand Vacations
HGV
$3.53B
| $3.46M | ﹤0.01% |
77,800
-285,900
| -79% | -$12.9M |
|
1695
Natural Health Trends
NHTC
$15.6M
| $3.46M | ﹤0.01% |
699,415
-18,567
| -3% | -$91.9K |
|
1696
Acadia Realty Trust
AKR
$2.86B
| $3.45M | ﹤0.01% |
247,001
-154,300
| -38% | -$2.24M |
|
|
ZEUS
1697
DELISTED
Olympic Steel
ZEUS
| $3.42M | ﹤0.01% |
65,599
+19,501
| +42% | +$901K |
|
1698
Kite Realty
KRG
$5.32B
| $3.42M | ﹤0.01% |
163,503
+134,203
| +458% | +$2.82M |
|
1699
German American Bancorp
GABC
$1.93B
| $3.42M | ﹤0.01% |
102,448
-5,200
| -5% | -$193K |
|
|
EVBG
1700
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $3.41M | ﹤0.01% |
98,400
+45,800
| +87% | +$1.46M |
|
Similar funds
Jim Simons's Q1 2023 Portfolio in Review
As of Q1 2023, Jim Simons held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Jim Simons added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Jim Simons's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Jim Simons fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Jim Simons's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Jim Simons opened 524 new positions and closed 668 in Q1 2023.
- Jim Simons's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.